Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1775 of 2529 entries
View as:

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04000529 Org: User:
Start: 07/30/19 End: 01/15/24 Due: 01/15/25

Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00667251 Org: User:
Start: 10/07/08 End: 07/27/22 Due: 07/27/23

Extended Evaluation of Deferasirox Film-coated Tablet (FCT) Formulation

Phase: N/A Priority: Normal
NCT ID: NCT02720536 Org: User:
Start: 08/16/16 End: 07/23/19 Due: 07/23/20

A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor

Phase: N/A Priority: Normal
NCT ID: NCT03312738 Org: User:
Start: 09/15/17 End: 04/25/22 Due: 04/25/23

Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00847678 Org: User:
Start: 08/31/06 End: - Due: -

Nilotinib Roll-over Protocol for Patients in Novartis-sponsored Nilotinib Study and Benefiting From Nilotinib Treatment

Phase: N/A Priority: Normal
NCT ID: NCT01863745 Org: User:
Start: 06/25/13 End: 10/02/23 Due: 10/02/24

Long Term Safety Study of NVA237 vs QAB149 in COPD Patients

Phase: N/A Priority: Normal
NCT ID: NCT01697696 Org: User:
Start: 10/31/12 End: 11/30/14 Due: 11/30/15

Efficacy and Safety of Zoledronic Acid in the Prevention and Treatment of Corticosteroid Induced Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT00100620 Org: User:
Start: 06/30/04 End: 04/30/07 Due: 04/30/08

The Purpose of This Study is to Investigate Safety and Tolerability of Tropifexor.

Phase: N/A Priority: Normal
NCT ID: NCT04408937 Org: User:
Start: 05/29/20 End: 11/04/20 Due: 11/04/21

A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT00421044 Org: User:
Start: 05/31/06 End: - Due: -

Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04410523 Org: User:
Start: 09/09/20 End: 09/06/22 Due: 09/06/23

A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)

Phase: N/A Priority: Normal
NCT ID: NCT01034163 Org: User:
Start: 06/30/10 End: 05/31/12 Due: 05/31/13

Study of Efficacy, Safety and Tolerability of ACZ885 (Canakinumab) in Patients With Pulmonary Sarcoidosis

Phase: N/A Priority: Normal
NCT ID: NCT02888080 Org: User:
Start: 12/19/16 End: 03/04/19 Due: 03/04/20

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Phase: N/A Priority: Normal
NCT ID: NCT05849298 Org: User:
Start: 01/03/24 End: 10/04/29 Due: 10/04/30

First-in-human Single Ascending Dose Study of LNA043 in Patients Scheduled for Total Knee Replacement

Phase: N/A Priority: Normal
NCT ID: NCT02491281 Org: User:
Start: 11/16/15 End: 03/06/18 Due: 03/06/19

Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Midazolam, Repaglinide, Dextromethorphan, Metformin, Rosuvastatin and Dolutegravir

Phase: N/A Priority: Normal
NCT ID: NCT05236530 Org: User:
Start: 03/09/22 End: 10/17/22 Due: 10/17/23

Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation Event

Phase: N/A Priority: Normal
NCT ID: NCT02661217 Org: User:
Start: 02/12/16 End: 06/20/18 Due: 06/20/19

Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS)

Phase: N/A Priority: Normal
NCT ID: NCT03713632 Org: User:
Start: 02/25/19 End: 07/19/22 Due: 07/19/23

Phase II Study to Investigate the Benefits of an Improved Deferasirox Formulation (Film-coated Tablet)

Phase: N/A Priority: Normal
NCT ID: NCT02125877 Org: User:
Start: 07/08/14 End: 02/24/16 Due: 02/24/17

Study of Efficacy and Safety of Inclisiran in Japanese Participants With High Cardiovascular Risk and Elevated LDL-C

Phase: N/A Priority: Normal
NCT ID: NCT04666298 Org: User:
Start: 01/29/21 End: 10/19/22 Due: 10/19/23

A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02565511 Org: User:
Start: 11/30/15 End: 04/30/20 Due: 04/30/21

A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection

Phase: N/A Priority: Normal
NCT ID: NCT01860989 Org: User:
Start: 07/31/13 End: 08/31/14 Due: 08/31/15

Assessment of Immune Response in Multiple Sclerosis Patients With COVID-19/Vaccination Treated With Ofatumumab and Other Disease Modifying Therapies

Phase: N/A Priority: Normal
NCT ID: NCT05950308 Org: User:
Start: 01/05/22 End: 07/14/22 Due: 07/14/23

2 Years Prospective Study to Collect Real-life Data on the Retention, Quality of Life, Effectiveness and Treatment Pattern of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis, Psoriatic Arthritis, Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis

Phase: N/A Priority: Normal
NCT ID: NCT05155098 Org: User:
Start: 03/25/22 End: 06/30/25 Due: 06/30/26

Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant

Phase: N/A Priority: Normal
NCT ID: NCT00565474 Org: User:
Start: 09/30/01 End: - Due: -